On March 22, 2023, Federal Minister of Health Jean-Yves Duclos announced $1.5 billion in funding associated with the government’s long anticipated national rare disease strategy first announced in 2019.Most of the funding – up to $1.4 billion – which is to be allocated over the next three years, ... Read More


BACKGROUNDThe National Advisory Committee on Immunization (NACI) provides the Public Health Agency of Canada (PHAC) with ongoing and timely medical, scientific, and public health advice relating to immunization.Traditionally, NACI reviewed safety, efficacy, immunogenicity, effectiveness and burden of illness in making recommendations for vaccine programs. PHAC has now expanded ... Read More


PMPRB and Health Canada held two technical briefings on the soon-to-be published final amendments to the Patented Medicines Regulations (PMR) on August 9th, 2019. This coincided with the pre-release of the final regulatory text and an updated Regulatory Impact Analysis Statement (RIAS). Publication in Canada Gazette II is expected August ... Read More


CADTH’s Pharmaceutical Reviews Updates are used to communicate new CDR and pCODR drug review processes updates to the public. PDCI has outlined below the key highlights from the most recent update. For more information on this review, please consult the CADTH’s website. CADTH has three new consultations ... Read More


On June 6th, 2019, Dr. Eric Hoskins, Chair of the Advisory Council on the Implementation of National Pharmacare, along with Mr. Vincent Dumez, Member of the Advisory Council on the Implementation of National Pharmacare announced the Advisory Council’s final recommendations and released the final report. One key issue to bear ... Read More


***Participation Requested*** Sharing Responses to the National Pharmacare Public Consultation Announced in the 2018 federal budget and chaired by former Ontario Health Minister Eric Hoskins, the Advisory Council on the Implementation of National Pharmacare is currently engaging in a national dialogue on how the federal government could implement ... Read More


Health Canada, CADTH, and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS) have officially launched efforts to align regulatory and health technology assessment (HTA) drug reviews for eligible submissions, effective immediately. Background The new process stems from Health Canada and HTAs recognizing the need for greater coordination of the ... Read More